First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient

Detalles Bibliográficos
Autores principales: Jehn, Ulrich, Altuner, Ugur, Pavenstädt, Hermann, Reuter, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573942/
https://www.ncbi.nlm.nih.gov/pubmed/36262114
http://dx.doi.org/10.3389/ti.2022.10846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573942/
https://www.ncbi.nlm.nih.gov/pubmed/36262114
http://dx.doi.org/10.3389/ti.2022.10846

Ejemplares similares